Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041349 | SCV000065042 | benign | not specified | 2012-07-06 | criteria provided, single submitter | clinical testing | Ala146Ale in exon 2 of LMNA: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue, is not located within t he splice consensus sequence, and has been identified in 2.5% (108/4406) of Afri can American chromosomes from a broad population by the NHLBI Exome Sequencing P roject (http://evs.gs.washington.edu/EVS/; dbSNP rs80356805). |
Gene |
RCV000041349 | SCV000170141 | benign | not specified | 2011-07-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000041349 | SCV000193522 | benign | not specified | 2016-06-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004528232 | SCV000316410 | benign | LMNA-related disorder | 2020-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Eurofins Ntd Llc |
RCV000041349 | SCV000331148 | benign | not specified | 2015-08-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001086851 | SCV000559820 | benign | Charcot-Marie-Tooth disease type 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000041349 | SCV000614030 | benign | not specified | 2017-07-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587594 | SCV000699969 | benign | not provided | 2016-09-19 | criteria provided, single submitter | clinical testing | Variant summary: The LMNA c.438C>T (p.Ala146Ala) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. 5/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 281/109760 control chromosomes (2 homozygotes), predominantly observed in the African subpopulation at a frequency of 0.0277371 (265/9554). This frequency is about 111 times the estimated maximal expected allele frequency of a pathogenic LMNA variant (0.00025), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign/likely benign. Taken together, this variant is classified as Benign. |
Ambry Genetics | RCV000617451 | SCV000735849 | benign | Cardiovascular phenotype | 2016-04-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000768711 | SCV000900081 | benign | Cardiomyopathy | 2015-10-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000768711 | SCV000910955 | benign | Cardiomyopathy | 2018-03-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000587594 | SCV002050075 | likely benign | not provided | 2021-09-27 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003996463 | SCV004840613 | benign | Primary dilated cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000041349 | SCV001916992 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041349 | SCV001951622 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041349 | SCV001976105 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000587594 | SCV002036471 | likely benign | not provided | no assertion criteria provided | clinical testing |